RIMAG GROUP (02522) has completed the acquisition of the target company's equity.

RIMAG GROUP (02522) announced that on April 26, 2026, the company, buyer RIMAG GROUP Medical Imaging (Hong Kong) Limited, seller 1 Sun Seeds Management Co., Limited, and target company 1 Hong Kong Sun Seeds Management Co., Limited entered into Stock Purchase Agreement 1, under which the buyer intends to purchase Target Equity 1 (100% equity of the target company 1) for a total consideration of HKD 185 million; The company, buyer, seller 2 Wing On Value 4 Limited Partnership Fund, and target company 2 Wingon Medical Technology Co., Limited entered into Stock Purchase Agreement 2, under which the buyer intends to purchase Target Equity 2 (100% equity of the target company 2) for a total consideration of HKD 168 million. The consideration will be paid by the company to the seller in the form of consideration shares. All conditions precedent to the acquisition have been fulfilled as of August 27, 2026. The company has transferred 5,736,500 treasury shares to seller 1 and has allotted and issued 23,206,000 new H shares, as well as allotted and issued 26,229,500 new H shares to seller 2 to pay the consideration. Therefore, the acquisition has been declared completed. As of the date of this announcement, the total number of issued shares of the company has increased to 450 million shares (including 107 million unlisted shares and 344 million H shares), and the company does not hold any treasury shares.